Afghanistan

affected by wild poliovirus type 1 and circulating vaccine-derived poliovirus type 2

Afghanistan is affected by ongoing endemic wild poliovirus transmission. The Global Polio Eradication Initiative is focusing on reaching every last child in Afghanistan with vaccines, strengthening surveillance and maintaining political commitment, financial resources and technical support at all levels.

Polio this week in Afghanistan

  • Two wild poliovirus type 1 (WPV1) cases were reported; one each in Khost and Paktika provinces.There are 46 WPV1 cases reported in 2020 so far while the total number of cases reported in 2019 remains 29.
  • One wild poliovirus type 1 (WPV1) positive environmental sample was reported in Hirat province.
  • Nine cVDPV2 cases were reported; one each in Hilmand, Jawzjan, Kabul, Kandahar, Khost, Laghman and Nimroz provinces, and two in Nangarhar province. There are 78 cVDPV2 cases reported in 2020 so far.
  • Read the latest polio snapshot from Afghanistan to see information on cases, surveillance and vaccination campaigns. 

International Health Regulations

Afghanistan is classified by the International Health Regulations (IHR) as a state infected with WPV1, cVDPV1 or cVDPV3 with potential risk of international spread. It is therefore subject to temporary recommendations as of June 2020.

loading map...
Key at-risk: no longer poliovirus-infected, but at high risk of outbreaks
Outbreak: has stopped indigenous WPV circulation but affected by outbreak of imported WPV or circulating vaccine-derived poliovirus
Endemic: has never stopped indigenous wild poliovirus (WPV) circulation

 Travel advice

WHO’s International Travel and Health recommends that all travellers to polio-affected areas be fully vaccinated against polio. Residents (and visitors for more than 4 weeks) from infected areas should receive an additional dose of OPV or inactivated polio vaccine (IPV) within 4 weeks to 12 months of travel.

Related Resources